Medicine

Social science offers valuable lessons about ways to convince those who are hesitant about the shots

Companies are scrambling to obtain supplies for hundreds of millions of doses of a type of vaccine that has never been made at this scale before

There is evidence the new variant could be more transmissible, yet vaccines work very well against it

Two RNA vaccines will be useful as U.S. infections surge, but the speedy authorizations complicate clinical trials

Treatments that reduce suffering and incorporate patient values aren’t common in kidney disease care. That’s changing

Demand for healthy kidneys has long outstripped supply. But better testing and treatment are expanding the donor pool

Minority patients are diagnosed later, stay on dialysis longer and are added to transplant lists less quickly. Why?

Nurse Kristen Choi says health care providers need to better educate patients about possible side effects from the COVID-19 vaccine. Christopher Intagliata reports.

Joint ventures between nephrologists and dialysis centers have expanded treatment. Critics ask: At what cost?

Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone's journey is the same

A new California law aims to curb what sponsors say is profiteering by dialysis centers. But are there any easy answers?

Even with vaccines on the way, treatments are needed to prevent the disease from getting worse—and to be ready for COVID-25, COVID-37, and so on